Prestige Consumer Healthcare, Inc. (PBH)
47.80
-1.66
(-3.36%)
USD |
NYSE |
Oct 23, 16:00
47.85
+0.05
(+0.10%)
After-Hours: 20:00
Prestige Consumer Healthcare Enterprise Value : 4.243B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.243B |
| October 22, 2026 | 4.321B |
| October 21, 2026 | 4.248B |
| October 20, 2026 | 4.317B |
| October 19, 2026 | 4.333B |
| October 16, 2026 | 4.343B |
| October 15, 2026 | 4.309B |
| October 14, 2026 | 4.271B |
| October 13, 2026 | 4.276B |
| October 12, 2026 | 4.300B |
| October 09, 2026 | 4.263B |
| October 08, 2026 | 4.246B |
| October 07, 2026 | 4.232B |
| October 06, 2026 | 4.178B |
| October 05, 2026 | 4.138B |
| October 02, 2026 | 4.122B |
| October 01, 2026 | 4.099B |
| September 30, 2026 | 4.151B |
| September 29, 2026 | 4.192B |
| September 28, 2026 | 4.201B |
| September 25, 2026 | 4.186B |
| September 24, 2026 | 4.141B |
| September 23, 2026 | 4.154B |
| September 22, 2026 | 4.239B |
| September 21, 2026 | 4.195B |
| Date | Value |
|---|---|
| September 18, 2026 | 4.109B |
| September 17, 2026 | 4.180B |
| September 16, 2026 | 4.198B |
| September 15, 2026 | 4.190B |
| September 14, 2026 | 4.234B |
| September 11, 2026 | 4.202B |
| September 10, 2026 | 4.221B |
| September 09, 2026 | 4.285B |
| September 08, 2026 | 4.337B |
| September 04, 2026 | 4.454B |
| September 03, 2026 | 4.468B |
| September 02, 2026 | 4.481B |
| September 01, 2026 | 4.472B |
| August 31, 2026 | 4.431B |
| August 28, 2026 | 4.464B |
| August 27, 2026 | 4.404B |
| August 26, 2026 | 4.449B |
| August 25, 2026 | 4.416B |
| August 24, 2026 | 4.443B |
| August 21, 2026 | 4.409B |
| August 20, 2026 | 4.372B |
| August 19, 2026 | 4.426B |
| August 18, 2026 | 4.374B |
| August 17, 2026 | 4.349B |
| August 14, 2026 | 4.412B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Supernus Pharmaceuticals, Inc. | 2.035B |
| Phibro Animal Health Corp. | 2.281B |
| Structure Therapeutics, Inc. | 172.64M |
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 29.18M |
| Revenue (Quarterly) | 265.71M |
| Total Expenses (Quarterly) | 236.53M |
| EPS Diluted (Quarterly) | 0.6129 |
| Gross Profit Margin (Quarterly) | 49.11% |
| Profit Margin (Quarterly) | 10.98% |
| Earnings Yield | 7.47% |
| Operating Earnings Yield | 12.60% |
| Normalized Earnings Yield | 7.472 |